Human health characteristic value detection method and eye wearable electronic device

Abstract

This application provides a method for detecting human health characteristics and an eye-wearable electronic device. The eye-wearable electronic device may include a first detector (e.g., millimeter-wave radar). When a user wears the eye-wearable electronic device, the first detector emits a first signal to the user's skin and receives a second signal reflected by the user's skin. The second signal is used to obtain at least one of blood pressure and blood sugar values, thereby enabling the eye-wearable electronic device to have the function of detecting human health characteristics.

Description

Technical Field

[0001] This application relates to the field of electronic devices, and in particular to a method for detecting human health characteristics and a wearable electronic device for the eyes. Background Technology

[0002] Currently, wearable electronic devices for the eye only have functions such as voice calls, taking photos and videos, display, and wireless connection, and do not yet have the function of detecting human health characteristics. Summary of the Invention

[0003] This application provides a method for detecting human health characteristics and an eye-wearable electronic device. When the user wears the eye-wearable electronic device, the device transmits a first signal to the detection target through a first detector and receives a second signal reflected by the detection target. The second signal is used to acquire at least one of blood pressure data and blood glucose data, thereby enabling the eye-wearable electronic device to have the function of detecting human health characteristics and increasing the applicability of the device.

[0004] In a first aspect, this application provides a wearable eye electronic device, which may include a first detector disposed within a first part of the wearable eye electronic device. The first part may include a nose pad or a frame of the wearable eye electronic device. When a user wears the wearable eye electronic device, the first detector is used to emit a first signal toward a detection target and receive a second signal reflected by the detection target. The second signal is used to acquire at least one of blood pressure and blood glucose values. Through the above configuration, the wearable eye electronic device possesses a human health characteristic value detection function, capable of detecting human blood pressure and / or blood glucose, which helps to diversify the functions of wearable eye devices and broaden their applications.

[0005] In one possible implementation, the detection target is the user's facial skin.

[0006] In one possible implementation, the aforementioned wearable eye electronic device may further include: a support portion disposed within the first part, the support portion being located between the surface of the first detector and the first part, such that the distance between the signal emission position of the first detector and the detection target meets the detection requirements for blood pressure-related data, thereby improving the accuracy of blood pressure detection.

[0007] In one possible implementation, the aforementioned wearable eye electronic device further includes a retractable device, wherein the first detector is fixed to a retractable end of the retractable device. When the retractable end extends, the first detector moves toward the user's skin; when the retractable end contracts, the first detector moves away from the user's skin. This allows the wearable eye electronic device to meet the requirements for blood pressure and blood sugar detection through the retractable device, thereby reducing the hardware cost of the wearable eye electronic device.

[0008] In one possible implementation, the retractable device includes a housing and a motor, a screw, and an internally threaded push rod disposed within the housing. The internally threaded push rod is threadedly connected to the screw. Driven by the motor, the screw rotates, pushing the internally threaded push rod out of the housing and bringing the first detector closer to the user's skin, allowing the second signal to be used to acquire the blood glucose level. Alternatively, the internally threaded push rod can be pulled back into the housing, moving the first detector away from the user's skin, allowing the second signal to be used to acquire the blood glucose level. When the first detector is fixed to the end of the internally threaded push rod extending from the housing, the first detector can move closer to or further away from the target when the motor is operating, thereby meeting the requirements for detecting blood pressure or blood glucose and improving detection accuracy.

[0009] In one possible implementation, the aforementioned wearable eye electronic device further includes at least one of a display and a speaker, the display being used to show at least one of the aforementioned blood pressure and blood glucose values, and the speaker being used to play audio recordings of the at least one of the blood pressure and blood glucose values. When the detection results of at least one of the blood pressure and blood glucose values ​​are provided to the user through the display or speaker, the user experience can be improved.

[0010] In one possible implementation, the aforementioned wearable eye electronic device further includes a first controller for controlling the retractable device to extend and retract, thereby enabling the retractable device to extend and retract under the control of instructions, thus improving the automation and intelligence level of the wearable eye electronic device.

[0011] In one possible implementation, the aforementioned wearable eye electronic device further includes a second controller, which is used to control the first detector to emit the first signal. For example, the second controller issues an instruction to the first detector to emit a single-tone continuous wave signal, so that the first detector emits a single-tone continuous wave signal according to the instruction, or the second controller instructs the first detector to emit a frequency-modulated continuous wave signal, etc., thereby improving the diversity of the signals emitted by the first detector and enabling the first detector to be used for various detection functions such as blood pressure detection, blood glucose detection, etc.

[0012] In one possible implementation, the aforementioned eye-wearable electronic device further includes an encapsulation portion located on the surface of the first part, which can make the eye-wearable device look more integrated and also improve the user's wearing experience.

[0013] In one possible implementation, the encapsulation portion can be a skin-friendly film, which ensures that the user's comfort while wearing the eye-wearable electronic device remains unchanged when the first detector is included in the eye-wearable electronic device.

[0014] In one possible implementation, the encapsulation part can be an electromagnetic wave-permeable resin to minimize the impact on detection, ensuring that the detection accuracy meets the requirements while satisfying user comfort.

[0015] In one possible implementation, the aforementioned wearable eye electronic device further includes a second detector, which includes an inertial measurement unit (IMU) device. The second detector is used to detect whether the aforementioned wearable eye electronic device is worn by a user, thereby enabling the wearable eye electronic device to perform effective detection only when the user is wearing it, effectively saving power consumption.

[0016] In one possible implementation, the aforementioned wearable eye electronic device also includes a switcher for controlling the switching of the detection function of the wearable eye electronic device between blood pressure detection function and blood glucose detection function, thereby improving the flexibility of the wearable eye electronic device in detecting human health characteristics and further enhancing the user experience.

[0017] In one possible implementation, the first detector described above includes millimeter-wave radar. Millimeter-wave radar can provide a superior detection signal for detecting blood pressure and / or blood glucose, thereby achieving the lowest possible hardware and power consumption cost.

[0018] Secondly, this application provides a method for detecting human health characteristics, which may include: emitting an electromagnetic signal toward a target on at least one side of a user's face; receiving an electromagnetic signal reflected from the target on at least one side of the face; and extracting detection data related to at least one of blood pressure and blood sugar. For example, by using a first detector located on the left or right side of an eye-wearable device, electromagnetic signals emitted toward a target on the user's face can be detected, and detection data related to blood pressure or blood sugar can be obtained, thus enabling the eye-wearable device to detect human health characteristics.

[0019] In one possible implementation, transmitting electromagnetic signals to at least one side of the user's face detection target may include: simultaneously transmitting electromagnetic signals to a first side face detection target and a second side face detection target; receiving the electromagnetic signals reflected by the at least one side face detection target may include: receiving the electromagnetic signals reflected by the first side face detection target and the second side face detection target respectively, which is beneficial to improving detection efficiency and detection accuracy.

[0020] In one possible implementation, the simultaneous transmission of electromagnetic signals to the first and second side face detection targets of the user may include: transmitting a first electromagnetic signal, such as a single-tone continuous wave signal, to the first side face detection target, and simultaneously transmitting a second electromagnetic signal, such as a frequency-modulated continuous wave signal, to the second side face detection target; the extraction of detection data related to at least one of blood pressure and blood glucose may include: extracting blood pressure-related detection data from the electromagnetic signal reflected by the first side face detection target, and extracting blood glucose-related detection data from the electromagnetic signal reflected by the second side face detection target, thereby achieving simultaneous detection of blood pressure-related detection data and blood glucose-related detection data.

[0021] In one possible implementation, after extracting detection data related to at least one of blood pressure and blood glucose, the method may further include: determining whether the number of tests has reached a preset value; if not, re-executing the above-mentioned method of transmitting electromagnetic signals to at least one side of the user's face to extract detection data related to at least one of blood pressure and blood glucose; if the preset value has been reached, calculating the blood pressure value based on the blood pressure-related detection data, and calculating the blood glucose value based on the blood glucose-related detection data. Calculating blood pressure and blood glucose values ​​using detection data obtained from multiple tests helps to further improve detection accuracy.

[0022] In one possible implementation, transmitting an electromagnetic signal to at least one side of the user's face detection target may include: transmitting an electromagnetic signal to the target on one side of the user's face; receiving the electromagnetic signal reflected from the target on one side of the face detection target may include: receiving the electromagnetic signal reflected from the target on one side of the face detection target. This unilateral detection of blood pressure and / or blood glucose-related data helps reduce hardware costs.

[0023] In one possible implementation, the process of emitting electromagnetic signals to at least one side of a user's face to extract detection data related to at least one of blood pressure and blood glucose can be performed cyclically. Each time the process is repeated, the electromagnetic signals emitted during the emission of electromagnetic signals to the user's face switch between a first electromagnetic signal and a second electromagnetic signal. This implementation obtains multiple sets of detection data through multiple detections, resulting in higher accuracy in calculating blood pressure and / or blood glucose values ​​based on these multiple sets of detection data.

[0024] In one possible implementation, after extracting detection data related to at least one of blood pressure and blood glucose, the method may further include: determining whether the number of detections related to blood pressure or blood glucose has reached a preset value; if the preset value has been reached, calculating the blood pressure or blood glucose value based on the blood pressure or blood glucose-related detection data; otherwise, continuing to transmit electromagnetic signals to at least one side of the user's face to extract detection data related to at least one of blood pressure and blood glucose. This implementation, by calculating the blood pressure or blood glucose value only after the number of detections has been reached, helps to improve the accuracy of the detection results.

[0025] In one possible implementation, the process of emitting electromagnetic signals to at least one side of a user's face to extract detection data related to at least one of blood pressure and blood glucose can be performed cyclically. Each time this process is executed, it is determined whether the number of detections related to blood pressure or blood glucose has reached a preset value. If the preset value has been reached, the blood pressure or blood glucose value is calculated based on the blood pressure or blood glucose-related detection data. Then, the electromagnetic signal emitted in the process of emitting electromagnetic signals to at least one side of the user's face is switched, and the cyclic execution of the emitted electromagnetic signals continues. Each time this process is executed, it is determined whether the number of detections related to blood pressure or blood glucose has reached a preset value. If the preset value has been reached, the blood glucose or blood pressure value is calculated based on the blood glucose or blood pressure-related detection data. This implementation provides a feasible method for eye-wearable electronic devices to switch between human health feature detection functions. Switching the function after each detection helps to ensure the uniformity of the detection sample distribution, thereby improving detection accuracy.

[0026] In one possible implementation, a first electromagnetic signal is emitted towards the detection target on the first side of the face at a distance greater than or equal to λ / 2π from the skin on the first side of the face, satisfying the distance requirement for blood pressure detection. Simultaneously, a second electromagnetic signal is emitted towards the detection target on the second side of the face at a distance close to zero from the skin on the second side of the face, satisfying the distance requirement for blood glucose detection. Here, λ is the wavelength of the first electromagnetic signal. This implementation allows wearable eye electronic devices to simultaneously detect blood pressure and blood glucose levels, helping to save detection time and improve user experience.

[0027] In one possible implementation, transmitting a first electromagnetic signal to the first side face detection target may include transmitting a single-tone continuous wave signal to the first side face detection target, which helps to reduce system power consumption and hardware costs.

[0028] In one possible implementation, transmitting a second electromagnetic signal to the second side detection target may include transmitting a frequency-modulated continuous wave signal to the second side detection target, which is beneficial to improving detection accuracy.

[0029] In one possible implementation, before transmitting the electromagnetic signal to at least one side of the user's face to detect the target, the method may further include: wearing detection, wherein, under normal wearing conditions, the method performs the transmission of the electromagnetic signal to at least one side of the user's face to detect the target, so as to achieve effective detection.

[0030] Thirdly, this application provides a computer-readable storage medium storing instructions that, when executed by a computer, cause the computer to perform the method described in any of the second aspects.

[0031] Fourthly, this application provides a chip system that performs the method described in any of the second aspects.

[0032] Fifthly, this application provides a computer program product that, when run on a computer, causes the computer to perform the method described in any of the second aspects.

[0033] In one possible design, the program in the fifth aspect can be stored wholly or partially on a storage medium packaged with the processor, or it can be stored wholly or partially on a memory not packaged with the processor. Attached Figure Description

[0034] Figure 1 This is a blood vessel map showing the distribution around one side of the eye socket of the person being detected in this embodiment of the application;

[0035] Figures 2(a) and (b) are examples of wearable electronic devices for the eyes in the embodiments of this application;

[0036] Figure 3 This is a schematic diagram of the millimeter-wave radar structure in an embodiment of this application;

[0037] Figure 4 This is a schematic diagram of the internal structure of the nose pad in an embodiment of this application;

[0038] Figure 5 This is a schematic diagram of another internal structure of the nose pad in an embodiment of this application;

[0039] Figure 6 This is a schematic diagram of another internal structure of the nose pad in an embodiment of this application;

[0040] Figure 7 This is a schematic diagram of another internal structure of the nose pad in an embodiment of this application;

[0041] Figure 8 This is a schematic diagram of another internal structure of the nose pad in an embodiment of this application;

[0042] Figure 9This is a schematic diagram of the internal structure of the frame in an embodiment of this application;

[0043] Figure 10 This is an example diagram of the wearable eye device facing the user in an embodiment of this application;

[0044] Figure 11 This is a schematic diagram showing the detection results in an embodiment of this application;

[0045] Figures 12(a), (b) and (c) are application examples of VR glasses in the embodiments of this application;

[0046] Figure 13 This is an example flowchart of a human health characteristic value detection method in the embodiments of this application;

[0047] Figure 14 This is another example flowchart of the human health characteristic value detection method in the embodiments of this application;

[0048] Figure 15 This is another example flowchart of the human health characteristic value detection method in the embodiments of this application. Detailed Implementation

[0049] The terminology used in the implementation section of this application is for the purpose of explaining specific embodiments of this application only, and is not intended to limit this application.

[0050] Generally speaking, measurements of health characteristics involving the circulatory system, such as pulse measurement (blood pressure measurement) and blood glucose level measurement, should ideally be taken directly opposite the arteries. The wrist has two main arteries, the radial and ulnar arteries, both located on the inner side of the wrist. However, users typically wear wearable devices on the outer side of their wrists, resulting in an undesirable measurement position for blood pressure or blood glucose, making it difficult to accurately measure the user's blood pressure and / or blood glucose levels.

[0051] Figure 1 The image shows a vascular map of the periorbital region on one side of a human eye. It should be understood that these blood vessels are located beneath the skin. Wearable eye electronic devices can measure a user's blood pressure and / or blood sugar levels by positioning the nose pad or frame of the device directly against certain arteries and veins around the user's periorbital region.

[0052] In some embodiments, the wearable electronic device for the eye can be glasses 10. In some embodiments, the wearable electronic device for the eye can be augmented reality (AR) glasses or virtual reality (VR) glasses.

[0053] Figure 2 shows a schematic wearable eye electronic device provided in an embodiment of this application. The wearable eye electronic device is illustrated using glasses 10 as an example. For example, glasses 10 with nose pads can be as shown in Figure 2(a). Glasses 10 includes temples 201, lenses 203, and nose pads 41. It should be understood that glasses 10 may also include other parts, such as a frame for fixing the lenses 203. In some embodiments, the glasses may be equipped with sensors (e.g., touch sensors, bone conduction sensors, photoelectric sensors, heart rate sensors, proximity sensors, ambient light sensors), processors, etc., the sensors used to detect the user's physiological data, and the processors processing and evaluating the physiological data. Optionally, the sensors and processors may be located in the temples 201 or in the nose pads 41. In some embodiments, the glasses may also include a speaker (not shown) for playing audio. For example, the sensors detect the user's physiological data, the processor processes the physiological data and outputs the user's physiological data processing result, and the speaker can notify the user of the processing result via voice broadcast. Optionally, the speaker may be located on the temples 201. Since the temples 201 of the glasses are in contact with the user's ears when the user wears them, placing a speaker on the temples 201 makes it easier for the user to hear the audio played by the glasses. In some embodiments, the glasses may also include a laser projection device (not shown in the figure), which is used to form a laser projection or holographic projection in front of the lens 203 for display to the user.

[0054] After the user wears the glasses 10 on their eyes, the nose pads 41 can contact the dorsal nasal artery 111 and the dorsal nasal vein 112, and / or the medial canthal artery 121 and the medial canthal vein 122.

[0055] When a user wears an eye-worn device, certain parts of the frame (e.g., Figure 10The arteries (491, 493, 495, 497, 492, 494, 496, 498) in the image can contact the user's arteries, such as the dorsal nasal artery 111 and dorsal nasal vein 112, the medial canthal artery 121 and medial canthal vein 122, the supratrochlear artery 131 and supratrochlear vein 132, the supraorbital artery 141 and supraorbital vein 142, the zygomaticotemporal artery 151 and zygomaticotemporal vein 152, the zygomaticofacial artery 161 and zygomaticofacial vein 162, and the infraorbital artery 171 and infraorbital vein 172. It should be understood that some wearable eye devices may directly contact multiple arteries and veins among these vessels. For example, in AR or VR glasses, the portion of the frame directly facing the upper eye socket may contact the supratrochlear artery 131 and supratrochlear vein 132, and the supraorbital artery 141 and supraorbital vein 142. For example, as shown in Figure 2(b), AR or VR glasses, when worn on the eyes, have their frames fixed around the eye sockets, almost touching all the aforementioned arteries and veins. Furthermore, when a user wears such an eye-wearable device, due to gravity, the frame and / or nose pads and / or temples of the eye-wearable device naturally contact the user's facial skin. Compared to wrist-worn smart devices, eye-wearable devices offer better stability, which is beneficial for measuring blood pressure and blood sugar levels, and also helps improve the reliability of continuous monitoring by the system.

[0056] In some embodiments, the wearable eye electronics may include a first detector.

[0057] In some embodiments, the first detector may be a millimeter-wave radar, an infrared sensor, an ultrasonic sensor, etc.

[0058] When a user wears this wearable eye electronic device, the first detector emits a first signal toward a detection target (e.g., the user's target artery and / or vein, or the user's facial skin) and receives a second signal reflected from the detection target. This second signal is used to acquire at least one of blood pressure and blood glucose values. The first detector can extract vascular-related data from the second signal, such as data related to blood pressure or blood glucose (referred to as detection data for ease of description). This detection data can be used to estimate blood pressure or blood glucose levels. Furthermore, compared to the wrist, the user's facial skin has less hair and sweat, making the wearable eye electronic device less susceptible to interference from hair and sweat during detection, resulting in high detection accuracy.

[0059] In some embodiments, the wearable eye electronic device may also include a calculation module (e.g., a processor) for calculating blood pressure or blood glucose levels based on the aforementioned detection data. The function of this calculation module can be implemented using a microcontroller unit (MCU), a central processing unit (CPU), a dedicated chip, or a programmable chip.

[0060] In some embodiments, the first signal emitted by the first detector is an electromagnetic signal with a frequency in the millimeter-wave band, for example, the frequency of the emitted electromagnetic signal is between 30 and 300 GHz. In some embodiments, the wavelength range of the emitted electromagnetic wave may be 1 to 10 millimeters.

[0061] In some embodiments, the first detector is a millimeter-wave radar, wherein the millimeter-wave radar includes a transmitting antenna and a receiving antenna. Figure 3 The diagram shown illustrates detection using millimeter-wave radar. The signal generated by the signal generator is split into two synchronously. One signal is transmitted via the transmitter (TX) antenna, and the other is transmitted to a mixer, where it is mixed with the signal received by the receiver (RX) antenna to generate an intermediate frequency (IF) signal. After being filtered by a low-pass filter (LPF), the signal is converted by an analog-to-digital converter (ADC) to obtain the aforementioned detection data.

[0062] In some embodiments, the electromagnetic signal emitted by the millimeter-wave radar may be a single-tone continuous wave signal or a single-frequency continuous wave signal. In some embodiments, the electromagnetic signal may be a frequency-modulated continuous wave (FMCW) signal.

[0063] When detecting blood pressure, the phase data of the intermediate frequency signal generated by the millimeter-wave radar mixing can be used to extract the user's facial blood vessels (e.g., Figure 1The tiny vibrations generated on the skin by the dorsal nasal artery 111 and medial canthal artery 121 (shown in the diagram) are used to extract pulse wave information. Pulse waves are generated by the collision of blood flow inside blood vessels with the vessel walls. According to known research findings, such as "Wearable millimeter-wave device for contactless measurement of arterial pulses" published in the IEEE Journal of Biomedical Circuits and Systems 13.6(2019):1525-1534, and "Noninvasive Continuous Blood Pressure Measurement with Wearable Millimeter-Wave Device" presented at the 17th IEEE International Conference on Wearable and Implantable Body Sensor Networks (BSN), pulse waves contain feature information associated with human blood pressure values. Based on the extracted pulse wave information, the aforementioned estimation module can calculate blood pressure values ​​using feature analysis algorithms or neural network algorithms.

[0064] Because millimeter-wave radar signals can penetrate several millimeters to centimeters into human skin tissue, the millimeter-wave radar antenna can be placed close to or attached to the user's skin surface when detecting blood glucose. Millimeter-wave radar signals can also reach blood vessels in the user's face (e.g., facial blood vessels). Figure 1The blood in the nasal dorsal artery and vein 111, 112 and / or the medial canthal artery and vein 121, 122 is shown. According to known research results such as "Glucose levels detection using mm-wave radar" published in the IEEE Sensors Journal 2.3 (2018):1-4 and "Blood glucose level monitoring using an FMCW millimeter-wave radar" published in the Remote Sensing Journal 12.3 (2020):385, the power spectral density of the intermediate frequency signal obtained after mixing processing of the signal received by the millimeter-wave radar RX end is highly correlated with human blood glucose levels. Based on the power spectral density of the intermediate frequency signal, the estimation module can estimate blood glucose levels using feature analysis algorithms or neural network algorithms.

[0065] In some embodiments, when detecting blood glucose, the signal received by the millimeter-wave radar RX end does not need to be processed by the mixer, LPF and ADC, and can be directly output to the calculation module for analysis and processing. The calculation module calculates the blood glucose value based on the antenna reflection coefficient and / or propagation coefficient.

[0066] When detecting blood pressure, the first signal emitted by the millimeter-wave radar's TX terminal is a single-tone continuous wave signal. Single-tone continuous wave signals are easier to generate than frequency-modulated continuous wave signals, and they also consume less power.

[0067] When detecting blood glucose, the first signal transmitted by the TX end of a millimeter-wave radar is a frequency-modulated continuous wave (FM continuous wave) signal. Compared to a single-tone continuous wave (STM) signal, the FM continuous wave signal provides richer power spectrum information, which is beneficial for calculating the power spectral density. Therefore, transmitting an FM continuous wave signal is superior for the TX end of a millimeter-wave radar.

[0068] When detecting blood pressure, pulse wave measurement is inaccurate within a distance of less than λ / 2π due to the near-field effect of the antenna. Therefore, the distance between the antenna and the skin must be greater than or equal to λ / 2π, where λ is the wavelength of the millimeter-wave radar signal and π is the constant pi. In some embodiments, the first detector is disposed within a first part of the wearable eye electronic device, which may include at least one of the nose pad, frame, or temple of the wearable eye electronic device. For example, the first detector is disposed in the hollow portion of the nose pad or frame, and the distance between the antenna of the first detector and the surface of the user's skin is greater than or equal to λ / 2π. In some embodiments, an encapsulation portion is disposed on the outer side of the first part. This encapsulation portion contacts the user's skin and may be a skin-friendly film to minimize the slight pressure exerted on the skin by the first detector. Optionally, the encapsulation portion may be made of an electromagnetic wave-permeable resin material with properties that do not interfere with the propagation of electromagnetic signals.

[0069] When the first detector detects data related to blood pressure, the depth of the hollow portion of the nose pad or frame can be greater than or equal to λ / 2π+H, where H is the thickness of the first detector. When the first detector detects data related to blood glucose, the depth of the hollow portion of the nose pad or frame can be approximately equal to the thickness of the first detector.

[0070] Typically, millimeter-wave radar includes an antenna. This antenna is encapsulated within one side of the millimeter-wave radar. During installation, one side of the millimeter-wave radar encapsulating the antenna may face the encapsulation or cavity (i.e., the surface of the first part mentioned above), while the other side faces the bottom of the cavity. In some embodiments, the first detector may be externally connected to an antenna.

[0071] In one embodiment, a cavity is provided in the nose pad 41, and a millimeter-wave radar 42 is disposed in the cavity, such as... Figure 4 As shown. Figure 4 for Figure 2a A cross-sectional view of the nose pad 41 along the AA' direction shows that the nose pad 41 has a cavity 471, and an encapsulation part 46 encapsulates the millimeter-wave radar within the cavity 471. The outer surface of the encapsulation part 46 is the portion of the nose pad 41 that contacts the skin. The millimeter-wave radar 42 is fixed to the bottom of the cavity 471, and the antenna side 421 of the millimeter-wave radar maintains a certain distance from the inner surface of the encapsulation part 46 to ensure that the distance between the antenna and the skin is greater than or equal to λ / 2π. The millimeter-wave radar 42 can obtain power from a battery via a wiring harness 45, or it can further provide detection data to a calculation module via the wiring harness 45. In another embodiment, the internal structure of the nose pad is as follows: Figure 5 As shown. The support portion 48 is disposed between the inner surface of the encapsulation portion 46 and the millimeter-wave radar 42 to ensure that the distance between the antenna and the skin is greater than or equal to λ / 2π.

[0072] When testing blood glucose, the antenna of the millimeter-wave radar should be as close as possible to or even attached to the skin surface to ensure that the millimeter-wave radar signal penetrates into the blood vessels inside the user's face. One implementation example... Figure 6 As shown, the cavity 472 in the nose pad 41 is shallower than the cavity 471, and the distance between the antenna 421 and the inner surface of the package 46 is 0 or close to 0.

[0073] In other embodiments, a retractable device can be provided between the millimeter-wave radar and the packaging unit to adjust the distance between the first detector and the skin, so that the distance between the first detectors can meet the requirements for both blood pressure detection and blood glucose detection, which helps to reduce hardware costs.

[0074] An implementation example Figure 7 and Figure 8 As shown, the spatial difference between cavity 473 and cavity 472 is not significant. A retractable device 44 is provided on the side of the millimeter-wave radar 42 facing away from antenna 421. When detecting blood pressure-related data, the retractable device 44 retracts, pulling the antenna 421 and the encapsulation part 46 a certain distance apart, satisfying the requirement that the distance between the antenna and the skin is greater than or equal to λ / 2π. When detecting blood glucose-related data, the retractable device 44 extends, shortening the distance between the antenna 421 and the encapsulation part 46 to satisfy the requirement that the distance between the antenna and the skin is approximately equal to 0. In some embodiments, to ensure that the nose pad thickness is normal or maintains a normal thickness, certain parts of the retractable device 44 may be disposed in the bracket 43 connecting the lens 40 and the nose pad 41. These certain parts may be other parts besides the part on the push rod that fixes the millimeter-wave radar.

[0075] In other embodiments, the cavity and its internal structure may also be disposed within the frame or temple of the mirror. One embodiment is as follows: Figure 9 As shown, a frame 49 is provided with Figure 7 The cavity and its internal structure are shown. In some embodiments, the portion of the lens frame 49 in which the first detector is disposed may be a portion of the lens frame 491 and / or 492 ( Figure 10 (As shown), or frame portions 493 and / or 494, or frame portions 495 and / or 496, or frame portions 497 and / or 498. In other embodiments, the frame may be provided with Figure 4 , Figure 5 , Figure 6 or Figure 7 The cavity and its internal structure are shown.

[0076] In some embodiments, the retractable device can be a miniature electric actuator. This miniature electric actuator has a simple structure and requires no complex hydraulic or pneumatic devices. The miniature electric actuator can be millimeter-sized. Micrometer-level control can be achieved by controlling a screw via a motor to extend and retract an internally threaded actuator. One end of the actuator can be fixedly connected to the side of the first detector facing away from the antenna. When detecting blood pressure-related data, the motor controls the actuator to retract, moving the first detector away from the user's skin, ensuring the distance between the antenna of the first detector and the skin is greater than or equal to λ / 2π. When detecting blood glucose-related data, the motor can extend the actuator via the screw, moving the first detector closer to the user's skin, bringing the antenna of the first detector as close to the skin as possible.

[0077] The first detector can be positioned in the frame in a manner similar to that described in the nose pad. If a portion of the frame of the wearable eye electronic device comes into contact with facial arteries and veins, the first detector can be positioned in that portion, directly facing the arteries and / or veins. One embodiment is as follows: Figure 8 As shown.

[0078] Typically, the nose pads or frames of wearable eye devices are symmetrical. In some embodiments, the aforementioned first detector may be disposed in one of the nose pads or frames for detecting data related to blood pressure and / or blood glucose. In some embodiments, the aforementioned first detector may be disposed in two symmetrical nose pads or frames, both of which can detect data related to blood pressure and blood glucose. In some embodiments, one nose pad or frame may be used for detecting data related to blood pressure, and the other nose pad or frame may be used for detecting data related to blood glucose.

[0079] In some embodiments, the wearable eye electronic device may further include a power source that provides power to the first detector. In some embodiments, the wearable eye electronic device itself is a smart device, including an electronic module and a power source for powering the electronic module. The first detector may share this power source with the electronic module. In some embodiments, the wearable eye electronic device itself is ordinary glasses, requiring an additional power source to power the first detector. The first detector and the power source may be connected via a wired connection or a wireless connection. The power source may be an inductive charger, a radio frequency identification (RFID) charger, etc., or a battery such as a secondary battery, rechargeable battery, or primary battery. The power source may also be an energy harvesting system such as a solar cell, piezoelectric system, thermoelectric element, or thermoelectric component, or any combination of the above forms, or any other suitable system.

[0080] In some embodiments, the wearable eye electronic device may further include a second detector. This second detector may be a capacitive sensor or an IMU device. The IMU device may include an accelerometer and a gyroscope, etc., and detects whether the user is wearing the wearable eye electronic device based on IMU data. When the second detector detects that the user is wearing the wearable eye electronic device, it can trigger the first detector to detect the target area.

[0081] In some embodiments, the wearable eye electronic device may further include a first controller. When the first detector in the wearable eye electronic device can detect both blood pressure-related data and blood glucose-related data, the first controller can control the extension and retraction of the retractable device to adjust the distance between the first detector and the user's skin. This ensures that when the wearable eye electronic device detects blood pressure or blood glucose-related data, the distance between the first detector and the skin meets the distance requirements between the antenna and the skin. The function of this first controller can be implemented through a microcontroller unit (MCU), a central processing unit (CPU), a dedicated chip, or a programmable chip.

[0082] In some embodiments, the wearable eye electronic device may also include a second controller. This second controller can control the first detector to emit corresponding types of signals according to the detection needs of the wearable eye electronic device, which helps reduce power consumption and hardware complexity. For example, when detecting blood pressure-related data, the second controller sends a control command to the signal generator to generate a single-tone continuous wave; when detecting blood glucose-related data, the second controller sends a control command to the signal generator to generate a frequency-modulated continuous wave, etc. The second controller may include an instruction receiving unit and an instruction processing unit, wherein the instruction receiving unit may be a pressing device, etc., and the function of the instruction processing unit may be implemented through a microcontroller unit (MCU), a central processing unit (CPU), a dedicated chip, or a programmable chip, etc.

[0083] In some embodiments, the wearable eye electronic device may further include a switcher. This switcher is used to switch the detection function of the wearable eye electronic device, such as switching the detection function from detecting blood pressure-related data to detecting blood glucose-related data. In some embodiments, when the switcher switches the detection function of the wearable eye electronic device to detect blood pressure-related data, the first controller sends a retractable control command to the retractable device based on the switching information. The retractable device moves the first detector away from the user's skin, ensuring that the distance between the antenna and the skin meets a distance requirement greater than or equal to λ / 2π. In another embodiment, the second controller sends a control command to the signal generator to generate and transmit a single-tone continuous wave signal based on the switching information. When the switcher switches the detection function of the wearable eye electronic device to detect blood glucose-related data, the first controller sends a retractable control command to the retractable device based on the switching information. The retractable device moves the first detector closer to the user's skin, ensuring that the distance between the antenna and the skin is as close to zero as possible. In another embodiment, the second controller sends a control command to the signal generator to generate and transmit a frequency-modulated continuous wave signal based on the switching information.

[0084] In some embodiments, the wearable eye electronic device may further include a communication module (e.g., a cable for wired communication, a Bluetooth transmitter or receiver for wireless communication). This communication module can be used for communication between the first detector and the calculation module. Alternatively, the communication module can be further used for communication between the first detector and some or all of the switch, second detector, first controller, and second controller.

[0085] Some or all of the aforementioned calculation module, second detector, first controller, second controller, and switcher communicate with the first detector via wired or wireless means. Exemplary communication systems include: 802.11x, Wireless Fidelity (WiFi), World Interoperability for Microwave Access (Wi-Max), Wireless Local Area Networks (WLAN), Near Field Communication (NFC), RFID, Bluetooth, Bluetooth Low Energy (BLE), ZigBee, cellular telecommunications, Radio Frequency (RF), microwave, infrared radiation (IR), audio, optical, or any other suitable communication method or combination thereof. In a preferred embodiment, the second detector, first controller, and second controller are wiredly connected to the first detector and are all mounted in the eye-wearable electronic device.

[0086] In some embodiments, the calculation module can be integrated with the first detector in an eye-wearable electronic device. For example, the calculation module can be housed in the temple of the eye-wearable electronic device. In one embodiment, a cable can be embedded in the frame, with one end connected to the first detector and the other end connected to the calculation module. In one embodiment, the eye-wearable electronic device is a smart wearable device such as AR glasses or VR glasses, and the calculation module can reuse a wireless communication module, such as a Bluetooth module, in its temple. The wireless communication module on the first detector side can be housed in the nose pad (where the internal space of the nose pad allows) or the connecting rod of the nose pad, or other suitable components. Alternatively, the calculation module can be housed in other suitable components of the eye-wearable electronic device. In some embodiments, the calculation module can be integrated in a smart electronic device such as a mobile phone or tablet, receiving detection data from the first detector by reusing the communication function of the smart electronic device. In some embodiments, the eye-wearable electronic device housing the first detector has a wireless communication module (such as a Bluetooth module), and the first detector can reuse the wireless communication module to send detection data to the calculation module. In some embodiments, the above-mentioned calculation module may be mounted in a control handle that is compatible with the eye-wearable electronic device.

[0087] In some embodiments, the wearable eye electronic device may further include a trigger module. This trigger module can trigger the wearable eye electronic device to perform detection when trigger conditions are met. In some embodiments, the trigger condition can be time or operation; for example, the trigger condition could be power-on or detection of a user input command (e.g., voice input, or touch input). In some embodiments, the trigger module can be a manual trigger switch (e.g., a touch sensor), located in a space-allowed and easily accessible position on the wearable eye device (e.g., on the temple), and communicates with the first detector via wired or wireless means. In some embodiments, the trigger module can be a software trigger button in a smart electronic device such as a mobile phone or tablet, multiplexing the communication function of the smart electronic device to send detection commands to the first detector. For example, the user touches the input via the trigger module, and the wearable eye electronic device begins detection. In some embodiments, the trigger module can be located in the control handle of the smart wearable eye device, multiplexing the communication function of the control handle to send detection commands to the first detector.

[0088] In some embodiments, the wearable eye electronic device may further include a display. The display may show the blood pressure or blood glucose value calculated by the aforementioned calculation module. In some embodiments, the display may be a liquid crystal display, a light-emitting diode (LED) display, an organic light-emitting diode (OLED) display, a virtual interface, etc. For example, the blood pressure value displayed may include the systolic pressure and diastolic pressure and / or mean pressure, such as "systolic: XXX, diastolic: XXX" or "systolic pressure: XXX, diastolic pressure: XXX, mean pressure: XXX", and the displayed blood glucose value may be "whole blood glucose: XXX mmol / L or mg / dL, plasma glucose: XXX mmol / L or mg / dL". In other embodiments, the display may further indicate whether the blood pressure or blood glucose value is normal. For example, the display may further display "normal blood pressure", "high blood pressure", or "low blood pressure". For example, the display may further display "normal blood glucose". In some embodiments, the display may further show health prompts such as "Blood sugar is abnormal, please test again to confirm" or "Blood sugar is abnormal, please seek medical attention promptly." In some embodiments, the display may be the display of a smart electronic device, reusing the display function of the smart electronic device. One embodiment is as follows: Figure 11 As shown, the phone screen displays blood pressure and blood glucose levels. In some embodiments, the display function of this screen can reuse the existing display functions of AR or VR glasses to display blood pressure and / or blood glucose levels.

[0089] In some embodiments, the wearable eye electronic device may further include a sound playback module (e.g., a speaker). This sound playback module can play the blood pressure or blood glucose values ​​calculated by the aforementioned calculation module. For example, the voice message might be "Your current blood pressure is XXX (systolic) and XXX (diastolic)" or "Your current whole blood glucose is XXX mmol / L, and your plasma glucose is XXX mmol / L." In some embodiments, the sound playback module can further play a voice message indicating whether the blood pressure or blood glucose values ​​are normal, such as "Your current blood pressure is normal," "Your current blood pressure is high," "Your current blood pressure is low," etc., or "Your current blood glucose is normal." In some embodiments, the sound playback module can further play health reminder messages such as "Please check your blood glucose again" or "Your blood glucose is abnormal; please seek medical attention promptly." In some embodiments, the sound playback module may be a speaker in a smart electronic device. In some embodiments, the sound playback module may be located in the wearable eye electronic device near the user's ear, and the played sound may be limited to the user's ears. Figure 10 As shown, the sound playback module is located in a portion 31 on the temple of the glasses, close to the user's ear.

[0090] In some embodiments, when the wearable electronic device for the eye is a smart wearable device such as AR glasses or VR glasses, at least one of the above-mentioned calculation module, second detector, first controller, second controller, and switcher can be implemented using the hardware device of the smart wearable electronic device itself, and the above-mentioned display and sound playback module can reuse the display and sound playback functions of the smart wearable device itself. As shown in Figures 12(a), 12(b), and 12(c), in one embodiment, the VR glasses 30 can display a virtual interface 60 for the user. The interface 60 can display an icon or button 61 for vascular detection. If the user selects the icon or clicks the button via the mobile phone 50, the VR glasses 30 further displays a blood pressure detection icon or button 61a, a blood glucose detection icon or button 61b, and an icon or button 61c for both detections. After the user selects 61a, 61b, or 61c via the mobile phone 50, the VR glasses trigger the second detector to detect whether the user is wearing the device correctly. If there is an error, a prompt message can be displayed to the user to prompt them to make adjustments. After the adjustments are correct, a message indicating that the device is wearing correctly, such as "OK" or "Correct," can be displayed. Then, if both sides of the VR glasses' first detectors can detect blood pressure and blood sugar, the first and second controllers can issue corresponding spacing control commands and signal type control commands according to the detection items selected by the user; if one side of the VR glasses' first detector is fixed to detect blood pressure and the other side's first detector is fixed to detect blood sugar, the switcher will switch to the other side for detection after a pre-set switching strategy, such as detecting a certain number of times or for a certain duration on each side. The detection data extracted by the first detectors can be used by the calculation module of the reused VR glasses to calculate the blood pressure value and / or blood sugar value, and displayed on the interface 60, or the voice result can be played through the VR glasses' speakers. In another embodiment, the interface 60 can directly display the blood pressure detection icon or button 61a and the blood sugar detection icon or button 61b. In one variation of this embodiment, the mobile phone is replaced by a computer or a controller. In another variation of this embodiment, the VR glasses are replaced by AR glasses, and the mobile phone is replaced by a controller.

[0091] Figure 13 An exemplary method for detecting human health characteristics is illustrated. This exemplary method is applicable to the aforementioned wearable eye electronic device, in which first detectors are disposed on both sides. The first detector on one side is fixed to detect blood pressure-related data, and the first detector on the other side is fixed to detect blood glucose-related data.

[0092] In step 131, the user initiates the blood pressure and blood sugar tests. For example, the user can initiate the tests via a trigger module, or by operating a smartphone or other smart electronic device to select a virtual icon or button displayed on the smart wearable electronic device to initiate the blood pressure and blood sugar tests.

[0093] In step 132, the eye-wearable electronic device first checks the wearing status of the eye-wearable device based on the IMU device. If the wearing is detected to be normal, the method can proceed to steps 1341 and 1342.

[0094] In step 1341, the first detector on the first side detects blood pressure-related data. The distance between the antenna of the first detector and the user's skin is fixed at λ / 2, and it transmits a single-tone continuous wave signal to the target blood vessel and receives the reflected signal to extract blood pressure-related data. The detection duration can be set according to the number of heartbeat cycles, for example, a blood pressure detection time of 5 seconds (approximately 3 to 5 heartbeat cycles) is set. After the detection duration is reached, the detection stops, and the method can proceed to step 135.

[0095] In step 1342, the first detector on the second side detects blood glucose-related data. The distance between the antenna of the first detector and the user's skin is fixed at almost zero, and it transmits a frequency-modulated continuous wave signal to the target blood vessel and receives the reflected signal to extract blood glucose-related data. The operation time of step 1342 can be the same as that of step 1341. After the operation time is reached, the method can proceed to step 135.

[0096] In step 135, the wearable electronic device for the eye determines whether the number of times steps 1341 and 1342 have been executed has reached a preset value. If not, the method returns to step 132; if the preset value has been reached, the method proceeds to step 136.

[0097] In step 136, the wearable electronic device for the eye analyzes and processes the detection data to obtain blood pressure and blood glucose values. As described above, the calculation module calculates the blood pressure and blood glucose values ​​based on the detection data related to blood pressure and blood glucose, respectively.

[0098] In step 137, the calculation module reports the blood pressure and blood sugar values, for example, by sending them to a smart electronic device such as a mobile phone for display or playback, or to the sound playback module of a wearable eye electronic device for playback, or to a smart wearable eye electronic device for display (through a monitor or by projecting through a laser projection device).

[0099] Step 135 above causes steps 1341 and 1342 to be repeated multiple times, which can improve the accuracy of blood pressure and blood glucose values. In a modified embodiment, step 135 above may be omitted.

[0100] Figure 14Another exemplary method for detecting human health characteristics is shown. This exemplary method is applicable to the aforementioned wearable eye electronic device, which has a first detector and a retractable device disposed on one side. The wearable eye electronic device also includes a first controller and a second controller. By configuring the first controller and the retractable device, the distance between the antenna of the first detector and the user's skin is adjustable. The second controller allows the type of electromagnetic signal emitted by the first detector to be adjustable.

[0101] In step 141, the user initiates the detection, similar to step 131. Step 142 is similar to step 132, and step 143 is similar to step 133, so they will not be described again here.

[0102] In step 144, the wearable eye electronic device determines that if it is the first detection, no switching will be performed. The first detection can be determined based on the initial state of the first detector. If the signal transmission type of the first detector is a single-tone continuous wave signal, and the distance between the antenna and the skin meets the requirements for blood pressure detection, then the first detection is for blood pressure-related data detection. If the signal transmission type of the first detector is an frequency-modulated continuous wave signal, and the distance between the antenna and the skin meets the requirements for blood glucose detection, then the first detection is for blood glucose-related data detection. Assuming that the initial state of the first detector is used to detect blood pressure-related data, the method can proceed to step 1451. Assuming that the initial state of the first detector is used to detect blood glucose-related data, the method can proceed to step 1452. If the wearable electronic device determines that this is not the first detection, it performs a switch. For example, if the previous detection was blood pressure, the current detection will be blood glucose. The distance between the antenna of the first detector and the skin is adjusted to approximately 0 using a retractable device. After the signal type emitted by the first detector is adjusted to a frequency-modulated continuous wave signal by the second controller, the method can proceed to step 1452. Conversely, if the previous detection was blood glucose, the current detection will be blood pressure. The distance between the antenna of the first detector and the skin is adjusted to ≥λ / 2. After the signal type emitted by the first detector is adjusted to a single-tone continuous wave signal, the method can proceed to step 1451.

[0103] Steps 1451 to 148 are similar to steps 1341 to 137 above, and will not be repeated here.

[0104] In this embodiment, the wearable electronic device switches between detection functions for each test, alternating between blood pressure and blood glucose detection. In a modified embodiment, each detection function is executed a predetermined number of times before switching to another. For example, blood glucose detection is performed only after the number of blood pressure-related data tests reaches a preset value, or vice versa. This modified embodiment only requires one switching operation, resulting in higher detection efficiency.

[0105] Figure 15 This illustrates another exemplary method for detecting human health characteristic values. This exemplary method is applicable to wearable electronic devices for the eye and... Figure 14 The difference between the eye-wearable electronic device used in the illustrated method embodiment is that the eye-wearable electronic device has a first detector and a retractable device on both sides.

[0106] Figure 15 In the illustrated method embodiment, steps 151 to 158 are similar to steps 141 to 148 described above. The difference lies in that steps 1551 and 1552 both involve simultaneously performing blood pressure-related or blood glucose-related tests on the blood vessels on both sides of the user's face. This allows for more reliable test data when the blood vessels on both sides of the user's face are not perfectly symmetrical, by integrating the data from both sides. In step 157, the calculation module first fuses the test data from both sides and then calculates the blood pressure and blood glucose values. Compared to... Figure 14 The embodiment shown has higher overall detection accuracy.

[0107] Another variation of this embodiment is that the wearable electronic device for the eye performs all the blood pressure or blood sugar related data detections before switching to another related data detection until the blood pressure and blood sugar values ​​are calculated. This process only involves one switch, which improves detection efficiency.

[0108] In the method described above, the wear detection and determination operations can be omitted. Another variation of the method described above is that the wearable electronic device can automatically perform detection after being powered on, without requiring user intervention.

[0109] In some embodiments, the wearable eye electronic device may include a first detection module. When a user wears the wearable eye device, the first detection module is disposed within a first part of the wearable eye electronic device, which may be a nose pad or a frame of the wearable eye electronic device. The first detection module is used to transmit a first signal to a detection target when the user wears the wearable eye electronic device, and to receive a second signal reflected by the detection target from the first signal. The second signal is used to obtain at least one of a blood pressure value and a blood glucose value.

[0110] In some embodiments, the above-mentioned wearable electronic device for the eye may further include: a retractable device, wherein the first detection module is fixed to one retractable end of the retractable device on the side facing the bottom of the first part.

[0111] In some embodiments, the above-mentioned wearable electronic device for the eye may further include: a first control module for controlling the stretchable device to extend or retract.

[0112] In some embodiments, the above-mentioned wearable eye electronic device may further include: a second detection module, used to detect the wearing status of the wearable eye electronic device, for example, to detect whether it is being worn by a user.

[0113] In some embodiments, the aforementioned wearable eye electronic device may further include at least one of a switching module, a triggering module, and a power supply. The switching module is used to switch the detection functions of the wearable eye electronic device, for example, controlling the wearable eye electronic device to switch between blood pressure detection and blood glucose detection functions. The triggering module is used to initiate detection by the electronic device, and the power supply is used to power the wearable eye electronic device.

[0114] In some embodiments, the first detection module described above can be used to extract detection data of at least one of blood pressure and blood glucose from the second signal described above.

[0115] In some embodiments, the above-mentioned wearable eye electronic device may further include a calculation module for calculating at least one of blood pressure and blood glucose values ​​based on the detection data.

[0116] In some embodiments, the above-mentioned wearable eye electronic device may further include at least one of a display module and a sound playback module, wherein the display module is used to display at least one of the blood pressure value and blood glucose value, and the sound playback module is used to play the voice of at least one of the blood pressure value and blood glucose value.

[0117] The module functions in the aforementioned wearable electronic devices for the eyes can be implemented through software within the hardware.

[0118] It is understood that some or all of the steps or operations in the above embodiments are merely examples, and other operations or variations thereof can be performed in the embodiments of this application. Furthermore, the steps may be performed in different orders as presented in the above embodiments, and it is not necessary to perform all the operations in the above embodiments.

[0119] This application also provides an electronic device, including: one or more processors; a memory; and one or more computer programs, wherein the one or more computer programs are stored in the memory, and the one or more computer programs include instructions that, when executed by the device, cause the device to perform the methods shown in the above embodiments.

[0120] This application also provides a computer-readable storage medium storing instructions that, when executed by a computer, cause the computer to perform the method provided in this application.

[0121] This application also provides a computer program product that, when run on a computer, causes the computer to execute the method provided in this application.

[0122] In this application embodiment, "at least one" refers to one or more, and "more than one" refers to two or more. "And / or" describes the relationship between related objects, indicating that three relationships can exist. For example, A and / or B can represent the existence of A alone, A and B simultaneously, or B alone. A and B can be singular or plural. The character " / " generally indicates that the preceding and following related objects are in an "or" relationship. "At least one of the following" and similar expressions refer to any combination of these items, including any combination of singular or plural items. For example, at least one of a, b, and c can represent: a, b, c, a and b, a and c, b and c, or a and b and c, where a, b, and c can be single or multiple.

[0123] Those skilled in the art will recognize that the units and algorithm steps described in the embodiments disclosed herein can be implemented using electronic hardware, computer software, or a combination of electronic hardware and software. Whether these functions are implemented in hardware or software depends on the specific application and design constraints of the technical solution. Those skilled in the art can use different methods to implement the described functions for each specific application, but such implementation should not be considered beyond the scope of this application.

[0124] Those skilled in the art will clearly understand that, for the sake of convenience and brevity, the specific working processes of the systems, devices, and units described above can be referred to the corresponding processes in the foregoing method embodiments, and will not be repeated here.

[0125] In the several embodiments provided in this application, any function, if implemented as a software functional unit and sold or used as an independent product, can be stored in a computer-readable storage medium. Based on this understanding, the technical solution of this application, in essence, or the part that contributes to the prior art, or a part of the technical solution, can be embodied in the form of a software product. This computer software product is stored in a storage medium and includes several instructions to cause a computer device (which may be a personal computer, server, or network device, etc.) to execute all or part of the steps of the methods described in the various embodiments of this application. The aforementioned storage medium includes various media capable of storing program code, such as USB flash drives, portable hard drives, read-only memory (ROM), random access memory (RAM), magnetic disks, or optical disks.

[0126] The above description is merely a specific embodiment of this application. Any variations or substitutions that can be easily conceived by those skilled in the art within the scope of the technology disclosed in this application should be included within the protection scope of this application. The protection scope of this application should be determined by the protection scope of the claims.

Claims

1. An eye-mountable electronic device, comprising: include: A first detector is disposed within the nose pad or frame of the wearable eye electronic device; the first detector is used to emit a first signal to the user's skin and receive a second signal reflected by the user's skin, wherein the second signal is used to obtain at least one of blood pressure and blood glucose values; The first detector includes a millimeter-wave radar, and the wearable eye electronic device further includes a second controller for controlling the first detector to emit the first signal. The control of the first detector to transmit the first signal includes: When detecting blood pressure, the first detector is controlled to emit a single-tone continuous wave signal; When detecting blood glucose, the first detector is controlled to emit a frequency-modulated continuous wave signal.

2. The eye-mountable electronic device of claim 1, wherein, The wearable electronic device for the eye also includes a support portion disposed within the nose pad or frame, the support portion being located between the first detector and the surface of the nose pad or frame.

3. The eye-mountable electronic device of claim 1, wherein, The wearable electronic device for the eye also includes: a retractable device, wherein the first detector is fixed to a retractable end of the retractable device; when the retractable end is extended, the first detector moves toward the user's skin; when the retractable end is contracted, the first detector moves away from the user's skin.

4. The eye-mountable electronic device of claim 3, wherein, The retractable device includes a housing and a motor, a screw, and an internally threaded push rod disposed within the housing. The internally threaded push rod is threadedly connected to the screw. The screw is used to rotate under the drive of the motor, pushing the internally threaded push rod out of the housing and causing the first detector to move closer to the user's skin, or pulling the internally threaded push rod back into the housing and causing the first detector to move away from the user's skin.

5. The eye-mountable electronic device of any one of claims 1 to 4, wherein, The wearable eye electronic device further includes at least one of a display and a speaker, the display being used to display at least one of the blood pressure value and the blood glucose value, and the speaker being used to play voice.

6. The eye-mountable electronic device of claim 3 or 4, wherein, The wearable electronic device for the eye also includes: a first controller for controlling the retractable device to extend and retract.

7. The eye-mountable electronic device of any one of claims 1 to 4, wherein, The wearable electronic device for the eye also includes an encapsulation portion located on the surface of the nose pad or the frame.

8. The eye-mountable electronic device of claim 7, wherein, The encapsulation part is a skin-friendly film.

9. The eye-mountable electronic device of claim 7, wherein, The encapsulation part is made of an electromagnetic wave-permeable resin.

10. The eye-mountable electronic device of any one of claims 1 to 4, wherein, The wearable eye electronic device further includes a second detector for detecting the wearing status of the wearable eye electronic device.

11. The eye-mountable electronic device of any one of claims 1 to 4, wherein, The wearable eye electronic device also includes a switcher for controlling the wearable eye electronic device to switch between blood pressure detection function and blood glucose detection function.

12. A method of detecting a human health characteristic value, characterized by, include: Electromagnetic signals are emitted toward at least one side of the user's face to detect a target, wherein the target is an artery or vein around the eye socket; Receive the electromagnetic signal reflected by the target on at least one side of the face; Extract test data related to at least one of blood pressure and blood sugar; The step of transmitting electromagnetic signals to at least one side of the user's face detection target includes: simultaneously transmitting electromagnetic signals to the user's first side face detection target and the second side face detection target. The simultaneous transmission of electromagnetic signals to the user's first and second side face detection targets includes: A first electromagnetic signal is emitted toward the first side surface detection target, and a second electromagnetic signal is emitted toward the second side surface detection target at the same time; Wherein, the first electromagnetic signal is a single-tone continuous wave signal, and the second electromagnetic signal is a frequency-modulated continuous wave signal; The extraction of detection data related to at least one of blood pressure and blood glucose includes: extracting blood pressure-related detection data from the electromagnetic signal reflected by the target on the first side face, and extracting blood glucose-related detection data from the electromagnetic signal reflected by the target on the second side face.

13. The method according to claim 12, characterized in that, Receiving the electromagnetic signals reflected by the at least one side of the face detection target includes: receiving the electromagnetic signals reflected by the first side face detection target and the second side face detection target, respectively.

14. The method of claim 12, wherein, After extracting test data related to at least one of blood pressure and blood glucose, the method further includes: If the number of detections has not reached a preset value, the process of transmitting electromagnetic signals to at least one side of the user's face is repeated until the detection data related to at least one of blood pressure and blood sugar is extracted. If the preset value has been reached, the blood pressure value is calculated based on the blood pressure-related detection data, and the blood sugar value is calculated based on the blood sugar-related detection data.

15. The method of claim 12, wherein, The step of transmitting an electromagnetic signal to a target for detecting at least one side of the user's face includes: transmitting an electromagnetic signal to a target for detecting one side of the user's face. Receiving the electromagnetic signal reflected by the target on at least one side of the face includes: receiving the electromagnetic signal reflected by the target on one side of the face.

16. The method according to claim 13 or 15, characterized in that The process of transmitting electromagnetic signals to at least one side of the user's face to detect a target, and extracting detection data related to at least one of blood pressure and blood sugar, is performed cyclically. Each time the process is repeated, the electromagnetic signals transmitted in the process of transmitting electromagnetic signals to at least one side of the user's face to detect a target switch between a first electromagnetic signal and a second electromagnetic signal.

17. The method of claim 13 or 15, wherein, The process of extracting test data related to at least one of blood pressure and blood glucose also includes: Determine whether the number of tests related to blood pressure or blood sugar has reached a preset value. If the preset value has been reached, calculate the blood pressure or blood sugar value based on the blood pressure or blood sugar related test data. Otherwise, continue to transmit electromagnetic signals to at least one side of the user's face to extract test data related to at least one of blood pressure and blood sugar.

18. The method of claim 13 or 15, wherein, The process involves transmitting electromagnetic signals to at least one side of the user's face to detect a target, and then repeatedly extracting detection data related to at least one of blood pressure and blood sugar. Each time the process is repeated, it is determined whether the number of detections of the blood pressure or blood sugar-related data has reached a preset value. If the preset value has been reached, the blood pressure or blood sugar value is calculated based on the blood pressure or blood sugar-related detection data. The electromagnetic signal transmitted in the process of transmitting electromagnetic signals to at least one side of the user's face to detect a target is then switched, and the transmission of the electromagnetic signal continues to be repeated. Each time the process is repeated, it is determined whether the number of detections of the blood pressure or blood sugar-related data has reached a preset value. If the preset value has been reached, the blood sugar or blood pressure value is calculated based on the blood sugar or blood pressure-related detection data.

19. The method of claim 13 or 14, wherein, At a position greater than or equal to λ / 2π away from the first side detection target, a first electromagnetic signal is emitted toward the first side detection target, and at the same position in contact with the second side detection target, a second electromagnetic signal is emitted toward the second side detection target; wherein λ is the wavelength of the first electromagnetic signal.

20. The method of claim 12, wherein, Before transmitting electromagnetic signals to at least one side of the user's face detection target, the method further includes: Wearing detection involves, under normal wearing conditions, transmitting electromagnetic signals to at least one side of the user's face to detect a target.

21. A chip system, characterized by Perform the method according to any one of claims 12 to 20.

22. A computer-readable storage medium, characterized in that, The computer-readable storage medium stores a computer program that, when run on a computer, causes the computer to perform the method described in any one of claims 12 to 20.

Images